The Current Role of Radiation in the Management of Cholangiocarcinoma—A Narrative Review
Cancers · 04.05.2024 · 16 (9) · 1776
DOI: 10.3390/cancers16091776 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 04.05.2024. Verfasst von Saurav Verma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Oncology, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 3K7, Canada. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cholangiocarcinoma (CCA) is a rare cancer of bile ducts. It is associated with a poor prognosis. The incidence of CCA is rising worldwide. Anatomical subgroups have been used to classify patients for treatment and prognosis. There is a growing understanding of clinically important distinctions based on underlying genetic differences that lead to different treatment options and outcomes. Its management is further complicated by a heterogeneous population and relative rarity, which limits the conduct of large trials to guide management. Surgery has been the primary method of therapy for localized disease; however, recurrence and death remain high with or without surgery. Therefore, there have been concerted efforts to investigate new treatment options, such as the use of neoadjuvant treatments to optimize surgical outcomes, targeted therapy, leveraging a new understanding of immunobiology and stereotactic radiation. In this narrative review, we address the evidence to improve suboptimal outcomes in unresectable CCA with radiation, as well as the role of radiation in neoadjuvant and postoperative treatment. We also briefly discuss the recent developments in systemic treatment with targeted therapies and immune checkpoint inhibitors.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Medical Oncology, Department of Oncology, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 3K7, Canada.
- London Regional Cancer Program, London Health Sciences Centre, London, ON N6A 5W9, Canada.
ORCID-Profile: Saurav Verma, Daniel Breadner, Michael Lock
Zitieren
APA
Verma, S., Grindrod, N., Breadner, D., & Lock, M. (2024). The Current Role of Radiation in the Management of Cholangiocarcinoma—A Narrative Review. Cancers, 16(9), 1776. https://doi.org/10.3390/cancers16091776
Vancouver
Verma S, Grindrod N, Breadner D, Lock M. The Current Role of Radiation in the Management of Cholangiocarcinoma—A Narrative Review. Cancers. 2024;16(9):1776. doi:10.3390/cancers16091776
BibTeX
@article{Verma2024,
author = {Verma, Saurav and Grindrod, Natalie and Breadner, Daniel and Lock, Michael},
title = {The Current Role of Radiation in the Management of Cholangiocarcinoma—A Narrative Review},
journal = {Cancers},
year = {2024},
volume = {16},
number = {9},
pages = {1776},
doi = {10.3390/cancers16091776}
}
EUVIMED